SFI
NVAX icon

Susquehanna Fundamental Investments’s Novavax NVAX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-94,916
Closed -$608K – 921
2025
Q1 		$608K Sell
94,916
-248,498
-72% -$2.05M 0.01% 800
2024
Q4 		$2.76M Buy
+343,414
New +$3.31M 0.04% 450
2024
Q2 		$4.35M Buy
343,414
+29,834
+10% +$300K 0.1% 252
2024
Q1 		$1.5M Buy
+313,580
New +$1.45M 0.07% 275
2022
Q4 		– Sell
-67,548
Closed -$1.23M – 1392
2022
Q3 		$1.23M Buy
+67,548
New +$2.93M 0.02% 737
2022
Q1 		$1.79M Buy
+24,308
New +$2.17M 0.03% 630

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna Fundamental Investments's NVAX Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Novavax (NVAX) in Q2 2025, closing a stake of 94,916 shares — an estimated $608K sold.

Susquehanna Fundamental Investments first reported a position in NVAX in Q1 2022 and held it in 6 quarters. The position peaked at $4.35M in Q2 2024. 251 funds tracked by Wall St. Rank hold NVAX as of Q2 2025.

  • Susquehanna Fundamental Investments reported no remaining Novavax position as of Q2 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 94,916 Novavax shares in Q2 2025, an estimated $608K.
  • Susquehanna Fundamental Investments first reported a position in Novavax in Q1 2022 and held it in 6 quarters.
  • Susquehanna Fundamental Investments's Novavax position peaked at $4.35M in Q2 2024.
  • 251 funds tracked by Wall St. Rank held Novavax as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.